Nicotinamide Vitamin B3 Derivative Cuts Risk Of New Skin Cancers
Friday, October 23, 2015 - 17:40
in Health & Medicine
A year of treatment with nicotinamide, a form of vitamin B3, significantly lowered the risk of common, non-melanoma skin cancer in high-risk patients, according to a paper in the New England Journal of Medicine. All 386 participants in the study had a history of skin cancer, increasing their risk for additional skin cancers. Taken as a twice-daily pill for 12 months, nicotinamide reduced the incidence of new non-melanoma skin cancers by 23 percent relative to placebo controls and cut the incidence of pre-cancerous sun spots by around 15 percent. read more